M&A and Fundraising Analysis for October 22, 2026

EstateMin: AI for inheritance law firms, 1 million euros to establish in the United States

Source: angelinvestorsnetwork.com →

EstateMin is an Irish platform founded in 2024, now based in New York, which develops an artificial intelligence tool for law firms specializing in inheritance and trust law. The company raises 1 million euros in pre-seed funding from NDRC, First Port Syndicate, Enterprise Ireland (via its High Potential Start-Up program), and several Irish business angels including Mike Hanrahan, Moira McKenna, and Conor Stanley. The funds will be used for customer acquisition, business development, and strengthening product and engineering teams in the United States. The company reports 20% monthly revenue growth.

This is a seed round in a narrow niche — inheritance law is a niche market, but with a captive clientele (specialized firms have repetitive case volumes and a high demand for document automation) and little direct competition in this specific segment.

Biogenera: A Bolognese biotech on crowdfunding, possibly heading for Euronext

Source: dealroom.co → · Sector FinTech — 📬 subscribe to the FinTech newsletter

Biogenera is an Italian biotech based near Bologna that develops anti-gene drugs based on its patented MyGenera platform. Its lead candidate, BGA002, targets aggressive pediatric cancers linked to MYCN amplification and has orphan drug status with the FDA and EMA — but the compound remains preclinical, with no human data. The company raises 667,469 euros via the crowdfunding platform CrowdFundMe, exceeding its minimum target of 249,984 euros, at a pre-money valuation of 90 million euros. The campaign closes on October 26. These funds will cover the regulatory work needed to launch a Phase I study at Padua Hospital in early 2027 — but completing the full Phase I would cost approximately 2.5 million euros, and total clinical development is estimated at 35 million.

Biogenera returns to crowdfunding for the third time (after 2.87 million in 2021 and 1.58 million in 2024), each time with an IPO announced as imminent — an aborted SPAC merger in 2020, unfulfilled Euronext Paris projects in 2021, 2022, and 2024. The amount raised today barely covers the first regulatory step of a program that requires thirty-five times more. For an investor evaluating this case: the science may be serious, but the funding path to the clinic remains entirely open.

Momentum Technologies / LifePods: Survival capsules, 400,000 euros in preparation

Source: lindependant.fr →

Momentum Technologies is a four-employee company based in Toulouges (Pyrénées-Orientales) that manufactures survival capsules under the LifePods brand — an anti-ballistic version resistant to military-grade weapon fire (B01, ICC 500 certified) and a version resistant to climatic hazards such as floods and tsunamis (W01). Its director, Cédric Choffat, is preparing a fundraising round of 400,000 euros for 4% of the capital, at an announced valuation of 10 million euros, with the support of BPI and the Foster fund from the Occitanie region. The B01 has attracted interest in the United States for hurricane protection; a salesperson has been hired to target the Japanese market.

This is a seed round for a company in the industrial incubation phase, with certifications obtained and markets to explore. The fundraising is not yet closed according to available information.

📩 Subscribe to our newsletter to follow daily M&A and fundraising news: https://proplace.co/newsletter

Fundbot: SME financing in the Mediterranean and Middle East, 2.6 million total

Source: investincotedazur.com → · Sector InsurTech — 📬 subscribe to the InsurTech newsletter

Fundbot is a Nice-based supply chain finance platform that enables banks and insurers to finance SME suppliers more quickly, using digital credit risk analysis tools. Founded in 2020, active in Lebanon, Jordan, and Egypt, it claims over 500 million dollars in financing granted to more than 3,000 SMEs in these markets. The company closes a complementary second seed round of 1.1 million dollars, led by Middle East Venture Partners (MEVP) and Salica Investment (who are reinvesting), with the arrival of Hub71 (Abu Dhabi). The total raised since 2023 reaches 2.6 million dollars. Two new markets will open in late 2026 and early 2027, and two new offerings complete the platform: credit insurance and co-financing funds alongside partner banks.

Fundbot's model is interesting precisely because it operates where traditional banks do not — SMEs in markets perceived as risky, with analysis tools that reduce the cost of risk assessment. The presence of Hub71, Abu Dhabi's tech hub, in this round signals an ambition to expand into the Gulf.

Pigment: The French financial planning platform aiming to compete with Oracle and Anaplan

Source: lesechos.fr → · Sector B2B Software & Cloud — 📬 subscribe to the B2B Software & Cloud newsletter

Pigment is a financial and operational planning platform founded in 2019, which enables finance, HR, and operations teams to build forecasting models, simulate scenarios, and manage company performance in real time. Its direct competitors are the major American platforms in the sector — Anaplan (acquired by Thoma Bravo), Adaptive Insights (Workday), Planful. The company closes a Series E of 250 million dollars led by the Scaleup Europe Fund, with Nvidia participating in the round. The valuation is not disclosed in available sources, but Les Echos indicates that it has increased compared to the previous round.

Nvidia's presence in the funding round is not anecdotal: it signals that Pigment integrates or plans to integrate intensive computing capabilities into its planning models — AI-assisted financial planning requires large-scale inference on sensitive enterprise data. For Pigment, it is also a signal of credibility in the American market, where the battle against established players is fought as much on technology as on the reputation of partners. Concretely, for a French CFO evaluating planning tools: Pigment is now one of the rare European players with the financial capacity and technological partnerships to stand up to American platforms on their own turf.

Dream Labs: 90 million for the brain of robots

Source: automate.org →

Dream Labs emerges from stealth mode, announcing a 90 million dollar seed round, co-led by B Capital and Kindred Ventures. The company is developing Dream-1, a foundational model trained on human interactions, designed to control any two-armed robotic system equipped with grippers. Within twenty-four hours of its launch, the model was reportedly used to control 31 types of robots it had never encountered during training. The funds will primarily be used to finance compute to expand the task library and increase the model's scale.

A 90 million dollar seed round for a company just emerging from stealth mode indicates where the competition in robotics is concentrated: not on metal and motors, but on general-purpose control software. Whoever builds the foundational model that all robot manufacturers will want to use captures a position analogous to that of an operating system — a royalty on every deployment. This is the bet that B Capital and Kindred are funding here.

ExponTech: Storage as the bottleneck for AI inference

Source: dealroom.co → · Sector Data & Analytics — 📬 subscribe to the Data & Analytics newsletter

ExponTech (华瑞指数云) is a Chinese distributed data storage startup that develops data management products for enterprise IT infrastructure, with a focus on domestic technology. It raises over 13.8 million dollars in a new round, co-led by Congbi Qiushi Investment with the participation of a public industrial fund. The capital is directed towards WQS, a KV Cache storage product designed specifically for large language model inference — the phase where an AI model generates its responses, which requires ultra-fast access to in-memory data. WQS is in production testing phase.

AI inference is the real mass market: training a model is done once, inference runs continuously for every query from every user. KV Cache storage is one of the concrete bottlenecks of this phase — and that's precisely where ExponTech is positioning its bet. In the context of Sino-American technological rivalry, the fact that a public industrial fund participates in the round signals that this computing infrastructure is considered strategic beyond just commercial stakes.